Pre-existing frontal lobe dysfunction signs as predictors of subsequent neurotoxicity in CAR T cell therapy: insights from a case series

BACKGROUND: Chimeric Antigen Receptor (CAR) T cell therapies are innovative treatments against hematological malignancies, with increasing therapeutic indications. Despite their great efficacy, these therapies are hampered by high rates of neurotoxicity (immune effector cell–associated neurotoxicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Fontanelli, Lorenzo, Pizzanelli, Chiara, Milano, Chiara, Cassano Cassano, Raffaella, Galimberti, Sara, Rossini, Maria Ida, Santo, Ignazio, Turco, Francesco, Bonanni, Enrica, Siciliano, Gabriele, Orciuolo, Enrico, Baldacci, Filippo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170036/
https://www.ncbi.nlm.nih.gov/pubmed/37160803
http://dx.doi.org/10.1007/s10072-023-06841-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10170036/
https://www.ncbi.nlm.nih.gov/pubmed/37160803
http://dx.doi.org/10.1007/s10072-023-06841-6

Ejemplares similares